Baijin Life Science Holdings Limited (HKG:1466)

Market Cap	503.42M +27.1%
Revenue (ttm)	119.80M +20.5%
Net Income	8.08M
EPS	0.01
Shares Out	932.25M
PE Ratio	53.90
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	160,000
Average Volume	160,805
Open	0.5200
Previous Close	0.5400
Day's Range	0.5200 - 0.5400
52-Week Range	0.4400 - 0.7600
Beta	-0.11
RSI	51.26
Earnings Date	Feb 26, 2026

About HKG:1466

Baijin Life Science Holdings Limited, an investment holding company, engages in the purchase, processing, design, production, assembly, trading, and wholesale distribution of jewelry products. The company operates through three segments: Jewellery Business, Strategic Investment, and Skincare Business. It is involved in the real estate financial assets investment business. The company also offers skincare solutions under the FO brand name; franchise licensing and consultation services; consultation and research and development services; skincare...

• Industry: Luxury Goods
• Sector: Consumer Discretionary
• Founded: 2014
• Employees: 79
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1466

Financial Performance

In fiscal year 2025, HKG:1466's revenue was 135.56 million, an increase of 152.54% compared to the previous year's 53.68 million. Losses were -316,000, -95.76% less than in 2024.